Do you understand what 'expanded access' means?
Expanded access is the term used to describe how manufacturers make new drugs that are being reviewed and available under certain circumstances to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial. If you have experience working with patients who have been given expanded access, share this. If you don't have personal experience, share your knowledge.
"It is my understanding that 'expanded access' is granted, under certain circumstances, to patients who do not qualify to participate in a clinical trial of a regulatory drug. The drug used in expanded access cannot expose patients to unreasonable risks given the severity of the disease, and the patient must not have any other satisfactory therapeutic options."
"I have some knowledge about 'expanded access,' although I have not worked directly with patients who have been granted expanded access. The manufacturer must be willing to make the drug available for expanded access use. The primary intent of expanded access is to provide treatment for a patient's disease or condition, rather than to collect data about the study drug."
Community answers are written by other candidates practicing this set. Reading how others frame the same question is one of the fastest ways to sharpen your own.
Anonymous Answer
Expanded access or 'compassion use' is a term used to describe a situation where a potential participant has little to no other treatment options available for a particular indication. The investigational product may be this participant's closest option to treatment and therefore should be open-label and pose no additional risk than had the participant not participated at all.
Stephanie's Feedback
This is a solid, well-rounded response that highlights your content knowledge once again.
